ATE47522T1 - Antiparasitaere nichtwaessrige formulierung ein avermektin oder milbemycin enthaltend. - Google Patents

Antiparasitaere nichtwaessrige formulierung ein avermektin oder milbemycin enthaltend.

Info

Publication number
ATE47522T1
ATE47522T1 AT84309044T AT84309044T ATE47522T1 AT E47522 T1 ATE47522 T1 AT E47522T1 AT 84309044 T AT84309044 T AT 84309044T AT 84309044 T AT84309044 T AT 84309044T AT E47522 T1 ATE47522 T1 AT E47522T1
Authority
AT
Austria
Prior art keywords
avermectin
milbemycin
antiparastic
formulation containing
aqueous formulation
Prior art date
Application number
AT84309044T
Other languages
English (en)
Inventor
James B Williams
Russell U Nesbitt
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE47522T1 publication Critical patent/ATE47522T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT84309044T 1983-12-22 1984-12-21 Antiparasitaere nichtwaessrige formulierung ein avermektin oder milbemycin enthaltend. ATE47522T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56414083A 1983-12-22 1983-12-22
EP84309044A EP0146414B1 (de) 1983-12-22 1984-12-21 Antiparasitäre nichtwässrige Formulierung ein Avermektin oder Milbemycin enthaltend

Publications (1)

Publication Number Publication Date
ATE47522T1 true ATE47522T1 (de) 1989-11-15

Family

ID=24253315

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84309044T ATE47522T1 (de) 1983-12-22 1984-12-21 Antiparasitaere nichtwaessrige formulierung ein avermektin oder milbemycin enthaltend.

Country Status (17)

Country Link
EP (1) EP0146414B1 (de)
JP (1) JPH0623100B2 (de)
KR (1) KR880002366B1 (de)
AT (1) ATE47522T1 (de)
AU (1) AU560864B2 (de)
CA (1) CA1267844A (de)
DE (1) DE3480263D1 (de)
DK (1) DK164772C (de)
ES (1) ES8608888A1 (de)
GR (1) GR81244B (de)
HK (1) HK5091A (de)
IE (1) IE57681B1 (de)
IL (1) IL73800A (de)
NZ (1) NZ210505A (de)
PT (1) PT79656B (de)
SG (1) SG97890G (de)
ZA (1) ZA849841B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2058244T3 (es) * 1987-01-23 1994-11-01 Pfizer Procedimiento para produccion de avermectinas y cultivos para el mismo.
US5075307A (en) * 1987-07-28 1991-12-24 Merck & Co., Inc. Paraherquamide and dihydroparaherquamide as antihelminthic agents
GB8803836D0 (en) * 1988-02-18 1988-03-16 Glaxo Group Ltd Compositions
US6001822A (en) * 1989-04-11 1999-12-14 Pfizer Inc. Antiparasitic formulations
US5169846A (en) * 1989-10-12 1992-12-08 Crooks Michael J Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators
NZ335166A (en) 1999-04-14 2001-11-30 Ashmont Holdings Ltd Anthelmintic composition containing triclabendazole in at least one solvent
GB2275193A (en) * 1993-02-17 1994-08-24 Merck & Co Inc Formulations for the topical delivery of avermectins
US5602107A (en) * 1993-05-10 1997-02-11 Merck & Co., Inc. Pour-on formulations consisting of gylcols, glycerides and avermectin compounds
PL173487B1 (pl) * 1993-05-10 1998-03-31 Merck & Co Inc Preparat do zwalczania wewnętrznych i zewnętrznych pasożytów zwierząt, sposób wytwarzania preparatu do zwalczania wewnętrznych i zewnętrznych pasożytów zwierząt oraz sposób zwalczania zewnętrznych pasożytów zwierząt
PL174488B1 (pl) * 1993-05-10 1998-08-31 Merck & Co Inc Preparat do zwalczania pasożytów zwierząt oraz sposób wytwarzania preparatu do zwalczania pasożytów zwierząt
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
ZA981925B (en) * 1997-03-21 1998-10-23 Biogenesis S A A long acting injectable parasiticidal composition and the process for its preparation
UY25089A1 (es) * 1997-07-10 2000-08-21 Hoechst Roussel Vet Gmbh Vacunas no acuosas
GB9816132D0 (en) * 1998-07-24 1998-09-23 Norbrook Lab Ltd Non-aqueous anthelmintic composition
AU733095B3 (en) * 1999-09-22 2001-05-03 Ashmont Holdings Limited Sheep pour on
JP2001253824A (ja) * 2000-03-14 2001-09-18 Mitsukazu Matsumoto 局所注射用処方剤
GR1003969B (el) * 2001-02-05 2002-08-14 U��-Pharma ����� ������ ������������ ���������� ���� Σταθερα φαρμακευτικα διαλυματα νιμεσουλιδης.
US6627613B2 (en) 2001-07-23 2003-09-30 Michael A. Strobel Application of water and organic solvent soluble ivermectin for topical and oral use
US20050009762A1 (en) 2003-06-06 2005-01-13 Strobel Michael Albert Application of water and organic solvent soluble ivermectin for topical and oral use
GB2386066A (en) 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
UY27412A1 (es) * 2002-08-12 2003-06-30 Carlson Internat Inc Un nuevo producto para el combate de garrapatas y el proceso para la prepaacinn.
GB0316377D0 (en) 2003-07-12 2003-08-13 Norbrook Lab Ltd Parasiticidal composition
JP4886214B2 (ja) * 2005-05-24 2012-02-29 日本パワーファスニング株式会社 石膏ボード締結用の2条式木ねじ
ES2617672T3 (es) 2008-10-08 2017-06-19 Zoetis Services Llc Composiciones antihelmínticas de bencimidazol
JP5607114B2 (ja) 2012-06-26 2014-10-15 株式会社トープラ タッピンねじ
JP2024516912A (ja) 2021-05-14 2024-04-17 シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト 昆虫、ダニ目及び線虫有害生物の防除
WO2022268815A1 (en) 2021-06-24 2022-12-29 Syngenta Crop Protection Ag Insect, acarina and nematode pest control

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144352A (en) * 1977-12-19 1979-03-13 Merck & Co., Inc. Milbemycin compounds as anthelmintic agents
US4130651A (en) * 1978-03-31 1978-12-19 American Cyanamid Company Butamisole injectable formulations having improved margin of safety in dogs
NZ197796A (en) * 1980-08-04 1984-11-09 Merck & Co Inc Stabilised aqueous formulations containing ivermectin
US4430329A (en) * 1982-05-17 1984-02-07 Merck & Co., Inc. Synergistic treatment of adult canine heartworm with thiacetarsamide and ivermectin

Also Published As

Publication number Publication date
EP0146414A2 (de) 1985-06-26
CA1267844A (en) 1990-04-17
AU3702484A (en) 1985-07-04
IE57681B1 (en) 1993-02-24
DK164772C (da) 1993-01-04
ES538750A0 (es) 1986-07-16
IL73800A (en) 1987-11-30
SG97890G (en) 1991-02-14
DK619784D0 (da) 1984-12-21
KR880002366B1 (ko) 1988-11-03
DK619784A (da) 1985-06-23
PT79656B (en) 1987-01-16
EP0146414B1 (de) 1989-10-25
IE843221L (en) 1985-06-22
NZ210505A (en) 1988-06-30
ZA849841B (en) 1986-07-30
DK164772B (da) 1992-08-17
AU560864B2 (en) 1987-04-16
GR81244B (en) 1985-04-16
PT79656A (en) 1985-01-01
ES8608888A1 (es) 1986-07-16
JPS60169415A (ja) 1985-09-02
IL73800A0 (en) 1985-03-31
HK5091A (en) 1991-01-18
DE3480263D1 (en) 1989-11-30
KR850004391A (ko) 1985-07-15
EP0146414A3 (en) 1986-12-10
JPH0623100B2 (ja) 1994-03-30

Similar Documents

Publication Publication Date Title
ATE47522T1 (de) Antiparasitaere nichtwaessrige formulierung ein avermektin oder milbemycin enthaltend.
SE8402551L (sv) Cinnamoylmoranolin-derivat
ES8607721A1 (es) Un procedimiento para la solubilizacion y estabilizacion de un agente antiparasitario.
IT1128094B (it) Catetere per la somministrazione en dovenosa intermittente di medicamenti
SE8306994D0 (sv) Cefemderivat och forfarande for deras framstellning
NO831610L (no) Fremgangsmaate for fremstilling av terapeutisk aktive oxicamderivater.
IT8323956A0 (it) Antibiotici macrolidi e preparazione orale stabile di procedimento di stabilizzazione.
MX9205384A (es) Dispositivo de administracion transdermica de un agente activo para uso veterinario.
DE19475001I2 (de) Anthelminthische Wirkstoffkombinationen.
GR3005423T3 (de)
ATE223221T1 (de) Lösliche arzneizusammensetzungen enthaltend 2- chloro-2'-deoxyadenosine
ES284914Y (es) Dispositivo para la administracion percutanea de un principio activo.
NO168648C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive nitrogenholdige derivater av epipodofyllotoksin-glukosidderivater.
GB2008944A (en) Copper compositions for topical application in the treatment of copper deficiency in animals
ES2040774T3 (es) Procedimiento para la preparacion de una formulacion medicamentosa.
NO160142C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (1,2,4)triazolo(4,3-a)kinoksalin-4-amin-derivater.
NO159590C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive fenyleddiksyre-derivater.
EP0093497A3 (de) Anthelmintische Behandlung
FI874400A0 (fi) Foerfarande foer framstaellning av imidazo-4,5-b pyridin-2-on-derivat.
SE8206128D0 (sv) Farmaceutisk komposition for behandling av njurstenar framkallade genom infektion
NO158062C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrido (1,4)benzodiazepiner.
AR241110A1 (es) Derivados de trihaloimidazol, composiciones insecticidas que los contienen como agente activo y metodo para producirlos.
FR2536073B1 (fr) Derives d'azepino (1,2-a) pyrimidine bronchodilatateurs, leurs sels d'addition d'acides et compositions pharmaceutiques qui les contiennent
AR224526Q (es) Derivados de s-fenoxi o feniltioalquil-n,n-dialquil-tiolcarbamatos y composiciones herbicidas,germicidas y acaricidas que los contienen como agente activo

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time